Immopharma SA
Immopharma reported total assets of 268,035 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Mar 2026).
The score of Immopharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -11 % Total assets -28 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Immopharma's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 31 Mar 2026
- Year ended 30 Sep 2024filed on 03 Apr 2025
- Year ended 30 Sep 2023filed on 05 Apr 2024
- Year ended 30 Sep 2022filed on 23 May 2023
- Year ended 30 Sep 2021filed on 28 Apr 2022
Immopharma's financial analysis
- Solvency83.1%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Immopharma
Immopharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0427.622.025
- VAT number
- BE0427622025
- Peppol
- Registered · 0208:0427622025 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 22 Nov 1984
- Registered office
- 9420 Erpe-Mere
- Latest accounts
- 2025 · filed on 31 Mar 2026
- Activity
- Rental and operating of own or leased non-residential real estate, except land (NACE 68203)
Immopharma (SA) has been based in Erpe-Mere since 1984, active in: rental and operating of own or leased non-residential real estate, except land. For 2025, it reports a net profit of 2,096 € and equity of 222,692 €; its revenue is not published. Its solvency stands at 83.1%, above the median of its sector (44.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Immopharma
Companies in the same business, of comparable size and area, outside its group.
- Centre LEVAO Rental and operating of own or leased real estate Hannut · balance sheet 163,137 €
- New Life Immo Rental and operating of own or leased real estate Visé · balance sheet 260,949 €
- XMP Immo Rental and operating of own or leased real estate Eupen · balance sheet 259,120 €
- Sanisa Rental and operating of own or leased real estate Arlon · balance sheet 281,175 €
- Drömbil Rental and operating of own or leased real estate Hulshout · balance sheet 5,050 €
- Hezimmo Rental and operating of own or leased real estate Hasselt · balance sheet 272,272 €
- Opti-Immo Rental and operating of own or leased real estate Eupen · balance sheet 287,872 €
- Romag Rental and operating of own or leased real estate Beringen · balance sheet 297,071 €
Frequently asked questions about Immopharma
What is the revenue of Immopharma?
Immopharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Immopharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0427622025 for Immopharma, if the company is VAT-registered. Its company number (CBE) is 0427.622.025.
Where is the registered office of Immopharma?
According to the CBE register, the registered office of Immopharma is in 9420 Erpe-Mere.
What is the equity of Immopharma?
At the close of the 2025 financial year, the equity of Immopharma amounts to 222,692 €, a solvency of 83.1% of total assets.
Who manages Immopharma?
The register lists 3 active mandates at Immopharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Immopharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →